Algo version: 0.98b
Anxo Pharmaceutical Co is listed at the TWO Exchange
Anxo Pharmaceutical Co [6677.TWO]
TWO Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Anxo Pharmaceutical Co stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Anxo Pharmaceutical Co pays dividends. Last time was Friday 13th of September 2024 where the investors holding the stock on Monday 26th of August 2024 were paid TWD0.39898 per share. Over the last 2 times between 2020 and 2024, Anxo Pharmaceutical Co has paid TWD0.62861 with an average of TWD0.31 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Anxo Pharmaceutical Co 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD32.85, you would have made a loss of TWD-4.50 per share or -13.70%

Yes, the average daily trading liquidity for Anxo Pharmaceutical Co is TWD48 038 thousand. You should therefore be able to get in and out of your positions relatively fast.

Anxo Pharmaceutical Co has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.05, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Anxo Pharmaceutical Co to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.